Recursion Pharmaceuticals Inc vs SMX Security Matters plc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while SMX Security Matters plc trades at $20 (market cap $16.38M). The key difference: Recursion Pharmaceuticals Inc is far larger — about 93.4× SMX Security Matters plc's market cap. Which is the better fit depends on your goals.
| RXRX | SMX | |
|---|---|---|
Market Cap | $1.53B | $16.38M |
Sector | Health | Technology |
52-Week High | $6.79 | $295.56K |
52-Week Low | $2.84 | $12.87 |
Enterprise Value | $946.50M | $13.35M |
Trailing returns across standard periods
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →